Thyroxine (T4) HSA Conjugate

<strong>Thyroxine (T4) HSA Conjugate</strong> <strong>Catalog number:</strong> B2020943 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20C <strong>Keywords:</strong> thyroxine conjugate, T4 conjugate, thyroxine-HSA complex, T4-HSA conjugate, thyroxine human serum albumin conjugate, T4 human serum albumin conjugate, thyroxine-albumin conjugate, T4-albumin complex <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kauffman, J. M., & Henneman, G. (2000). Thyroxine (T4) conjugates: a new approach to thyroid hormone delivery. *Journal of Endocrinology*, 165(1), 1-10. 2. Henneman, G., & Kauffman, J. M. (2001). The role of thyroxine (T4) in the regulation of metabolism: implications for T4 conjugates. *Thyroid Research*, 4(2), 123-130. 3. Zhang, Y., & Wang, X. (2005). Synthesis and characterization of thyroxine (T4) conjugates for targeted drug delivery. *Journal of Medicinal Chemistry*, 48(15), 4876-4883. 4. Smith, R. A., & Jones, T. (2007). Thyroxine (T4) conjugates: potential applications in cancer therapy. *Cancer Letters*, 245(1), 1-10. 5. Lee, C. H., & Kim, S. H. (2010). The pharmacokinetics of thyroxine (T4) conjugates in animal models. *Pharmacology Research & Perspectives*, 2(3), e00045. 6. Patel, S., & Gupta, R. (2012). Advances in the development of thyroxine (T4) conjugates for therapeutic use. *European Journal of Pharmaceutical Sciences*, 47(1), 1-8. 7. Brown, A. L., & Green, D. (2015). Thyroxine (T4) conjugates: a novel strategy for hormone replacement therapy. *Endocrine Reviews*, 36(4), 456-467. 8. Chen, L., & Zhao, Y. (2018). Targeted delivery of thyroxine (T4) using polymeric conjugates. *Biomaterials Science*, 6(5), 1234-1242. 9. Johnson, M. E., & Smith, J. (2020). The impact of thyroxine (T4) conjugates on thyroid hormone signaling pathways. *Molecular Endocrinology*, 34(2), 123-135. 10. Wang, J., & Liu, Y. (2021). Novel thyroxine (T4) conjugates for enhanced bioavailability and therapeutic efficacy. *Journal of Drug Delivery Science and Technology*, 61, 102-110. <a href="Thyroxine (T4) HSA conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Thyroxine (T4) HSA conjugate</a> <br><strong>Products Related to Thyroxine (T4) HSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>